Torreele E, Boum Y, Adjaho I, Alé FGB, Issoufou SH, et al.
2023-01-19 • Lancet Infectious Diseases
2023-01-19 • Lancet Infectious Diseases
Three years since proving effective for Ebola virus disease in a clinical trial, two breakthrough treatments are registered and stockpiled in the USA but still not registered and general...
• Limited access to vaccines by African nations as Africa has been side-lined in the race to secure vaccines for COVID-19. •. Uniform thinking and planning o...
2017-05-01 • Bulletin of the World Health Organization
To the Editor: We agree with Mr Folkers and Dr Fauci that the success of acquired immunodeficiency syndrome research over the last 2 decades shows what can be achieved if enough financia...
Guthmann JP, Arlt D, Garcia LML, Rosales M, Jesus Sanchez J, et al.
2005-09-01 • Tropical Medicine and International Health
2005-09-01 • Tropical Medicine and International Health
Mucocutaneous leishmaniasis (MCL) is an important health problem in many rural areas of Latin America, but there are few data on the results of programmatic approaches to control the dis...
Trouiller P, Olliaro PL, Torreele E, Orbinski J, Laing R, et al.
2002-06-22 • Lancet
2002-06-22 • Lancet
There is a lack of effective, safe, and affordable pharmaceuticals to control infectious diseases that cause high mortality and morbidity among poor people in the developing world. We an...
